Director, Machine Learning Research & Development Alex drives the development of iBio’s machine learning branch for epitope-steered antibody discovery. He has built his career around integrating machine learning into biotechnology platforms to solve problems in healthcare. With more than a decade of experience as a Ph.D. in computational biology, Alex has over 30 publications to …
Senior Platform Manager Cody develops iBio’s systems for in-vitro display, automation, and multi-specific antibody development. He is passionate about designing integrated laboratory and computational systems to solve complex biological problems. Before iBio, Cody was the first scientist at RubrYc Therapeutics, where he was responsible for establishing in-vitro display and sequencing capabilities while connecting them to …
Vice President, Platform Technology and Machine Learning Matt is the mastermind behind iBio’s technology platform and oversees the development of iBio’s tech stack. He is driven by a passion to utilize the power of integrated computation and laboratory discovery to solve difficult problems in human health. Growing up on a farm too far to walk …
Mr. Clark has more than 30 years of biotechnology and pharmaceutical experience, with a focus on business development, commercialization, strategic planning, and general management. Since 2011, he has served as the President and Chief Executive Officer of Nasdaq-listed biopharmaceutical company, Genocea Biosciences, Inc. In that role, among other accomplishments, he executed Genocea’s successful strategic pivot …
Dr. Linda Armstrong has more than 20 years of experience in biopharmaceutical research. She currently leads the Global Respiratory Development Unit at Novartis. She has served in a range of executive roles across R&D disciplines including Clinical Development, Patient Safety and Medical Affairs, supporting the development of small molecules, biologics and cell and gene therapies. …